스마트 만성 질환 관리 도구 시장 분석 및 예측(-2035년) : 유형, 제품, 서비스, 기술, 구성 요소, 용도, 디바이스, 도입 형태, 최종 사용자, 솔루션

The global Smart Chronic Disease Management Tools Market is projected to grow from $4.5 billion in 2025 to $9.2 billion by 2035, at a compound annual growth rate (CAGR) of 7.4%. Growth is driven by increasing prevalence of chronic diseases, advancements in digital health technologies, and rising demand for personalized healthcare solutions. The Smart Chronic Disease Management Tools Market is characterized by a moderately consolidated structure, with the top segments being remote patient monitoring systems (approximately 35% market share), mobile health applications (30%), and wearable devices (25%). Key applications include diabetes management, cardiovascular disease monitoring, and respiratory disease management. The market is driven by increasing installations of connected devices, with a significant volume of wearable devices being adopted globally.

The competitive landscape features a mix of global and regional players, with global companies such as Medtronic and Philips Healthcare leading the market. There is a high degree of innovation, particularly in AI-driven analytics and personalized health solutions. Mergers and acquisitions, as well as strategic partnerships, are prevalent as companies seek to expand their technological capabilities and market reach. Recent trends indicate a growing focus on integrating telehealth services with chronic disease management tools, enhancing patient engagement and outcomes.

The Type segment in the Smart Chronic Disease Management Tools Market is primarily driven by wearable devices and mobile applications, which dominate due to their accessibility and ease of use. These tools are crucial for continuous health monitoring and data collection, enabling proactive disease management. The demand is notably high in the healthcare and wellness industries, where real-time data can significantly enhance patient outcomes. The integration of AI and machine learning in these tools is a growing trend, facilitating personalized healthcare solutions.

In the Technology segment, cloud-based solutions lead the market, offering scalability, data security, and remote access to health data. These technologies are pivotal for healthcare providers to manage large datasets and improve patient care coordination. The rise of telemedicine and remote patient monitoring is driving demand, as these technologies enable efficient and cost-effective healthcare delivery. The trend towards interoperability and integration with existing healthcare systems is further propelling growth.

The Application segment sees the highest demand in diabetes and cardiovascular disease management, reflecting the prevalence of these conditions globally. These applications are essential for tracking vital health metrics and providing actionable insights to both patients and healthcare providers. The growing emphasis on preventive healthcare and the shift towards value-based care models are key factors driving this segment. Innovations in predictive analytics are enhancing the effectiveness of these applications, supporting early intervention strategies.

In the End User segment, healthcare providers and patients are the primary users, with providers leveraging these tools for improved patient engagement and care management. Patients benefit from increased autonomy and awareness of their health conditions. The rise of patient-centric care models and the increasing adoption of digital health solutions in clinical settings are significant trends. As healthcare systems worldwide strive for efficiency, the demand for these tools is expected to rise, particularly in developed markets.

The Component segment is dominated by software solutions, which are integral for data analysis, visualization, and user interface functionalities. These components are crucial for transforming raw health data into meaningful insights, aiding in clinical decision-making. The growing focus on user-friendly interfaces and enhanced data security measures is driving innovation in this segment. As the market evolves, the integration of advanced analytics and AI capabilities into software solutions is anticipated to further enhance their value proposition.

Geographical Overview

North America: The Smart Chronic Disease Management Tools Market in North America is highly mature, driven by advanced healthcare infrastructure and significant investment in digital health technologies. The United States leads the region, with strong demand from the healthcare and insurance industries aiming to reduce costs and improve patient outcomes. Canada also contributes to market growth with its focus on integrating technology into healthcare.

Europe: Europe exhibits moderate market maturity, with a strong emphasis on regulatory compliance and data privacy. The demand is primarily driven by the healthcare and pharmaceutical industries. Germany, the United Kingdom, and France are notable countries, leveraging government initiatives to enhance digital health solutions and chronic disease management.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in the Smart Chronic Disease Management Tools Market, fueled by increasing healthcare needs and technological advancements. Key industries include healthcare providers and technology firms. China, Japan, and India are significant contributors, with government support and a rising prevalence of chronic diseases driving demand.

Latin America: The market in Latin America is in the early stages of development, with growing awareness of digital health solutions. The healthcare and insurance sectors are key drivers, seeking to improve chronic disease management. Brazil and Mexico are notable countries, focusing on expanding healthcare access and integrating smart technologies.

Middle East & Africa: The Middle East & Africa region shows nascent market maturity, with increasing investments in healthcare infrastructure. The demand is driven by the healthcare industry, aiming to address the rising burden of chronic diseases. The United Arab Emirates and South Africa are notable countries, investing in digital health initiatives to enhance patient care and management.

Key Trends and Drivers

Trend 1 Title: Integration of AI and Machine Learning

The Smart Chronic Disease Management Tools market is increasingly leveraging AI and machine learning to enhance predictive analytics and personalized treatment plans. These technologies enable the analysis of vast datasets to identify patterns and predict disease progression, allowing for more proactive and tailored interventions. This trend is driven by the need for more efficient management of chronic conditions, reducing hospital visits, and improving patient outcomes through data-driven insights.

Trend 2 Title: Expansion of Remote Monitoring Solutions

Remote monitoring technologies are becoming a cornerstone in chronic disease management, allowing patients to track their health metrics from home. This trend is fueled by advancements in wearable devices and IoT connectivity, providing real-time data to healthcare providers. The COVID-19 pandemic accelerated the adoption of these solutions, highlighting their importance in reducing the burden on healthcare systems and enabling continuous patient care without the need for in-person visits.

Trend 3 Title: Regulatory Support and Reimbursement Policies

Governments and healthcare regulators are increasingly recognizing the value of digital health solutions in managing chronic diseases. Supportive regulatory frameworks and reimbursement policies are being established to encourage the adoption of smart management tools. These policies are crucial in driving market growth, as they lower financial barriers for healthcare providers and patients, facilitating broader access to innovative technologies.

Trend 4 Title: Interoperability and Data Integration

The demand for interoperable systems that can seamlessly integrate with existing healthcare infrastructure is rising. Interoperability allows for the efficient exchange of patient data across different platforms, enhancing care coordination and decision-making. This trend is driven by the need for comprehensive patient records that provide a holistic view of an individual's health, enabling more effective management of chronic conditions.

Trend 5 Title: Personalized Medicine and Genomic Insights

The shift towards personalized medicine is gaining momentum in the chronic disease management sector. Advances in genomic research and biotechnology are enabling more precise and individualized treatment plans. By understanding a patient's genetic makeup, healthcare providers can tailor interventions to improve efficacy and reduce adverse effects. This trend is supported by ongoing research and development efforts, as well as increasing collaboration between tech companies and healthcare providers to integrate genomic insights into smart management tools.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by Device
• 2.8 Key Market Highlights by Deployment
• 2.9 Key Market Highlights by End User
• 2.10 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Wearable Devices
  • 4.1.2 Mobile Applications
  • 4.1.3 Telehealth Platforms
  • 4.1.4 Remote Monitoring Systems
  • 4.1.5 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Blood Glucose Monitors
  • 4.2.2 Smart Insulin Pens
  • 4.2.3 Digital Blood Pressure Monitors
  • 4.2.4 Smart Inhalers
  • 4.2.5 Heart Rate Monitors
  • 4.2.6 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Patient Monitoring Services
  • 4.3.2 Data Analytics Services
  • 4.3.3 Consultation Services
  • 4.3.4 Chronic Care Management
  • 4.3.5 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Artificial Intelligence
  • 4.4.2 Machine Learning
  • 4.4.3 IoT
  • 4.4.4 Cloud Computing
  • 4.4.5 Data Analytics
  • 4.4.6 Blockchain
  • 4.4.7 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Sensors
  • 4.5.2 Software
  • 4.5.3 Connectivity Modules
  • 4.5.4 User Interface
  • 4.5.5 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Diabetes Management
  • 4.6.2 Cardiovascular Disease Management
  • 4.6.3 Respiratory Disease Management
  • 4.6.4 Hypertension Management
  • 4.6.5 Others
• 4.7 Market Size & Forecast by Device (2020-2035)
  • 4.7.1 Smartphones
  • 4.7.2 Tablets
  • 4.7.3 Wearables
  • 4.7.4 Connected Medical Devices
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Deployment (2020-2035)
  • 4.8.1 On-Premise
  • 4.8.2 Cloud-Based
  • 4.8.3 Hybrid
  • 4.8.4 Others
• 4.9 Market Size & Forecast by End User (2020-2035)
  • 4.9.1 Hospitals
  • 4.9.2 Homecare Settings
  • 4.9.3 Clinics
  • 4.9.4 Research Institutes
  • 4.9.5 Others
• 4.10 Market Size & Forecast by Solutions (2020-2035)
  • 4.10.1 Integrated Solutions
  • 4.10.2 Standalone Solutions
  • 4.10.3 Customizable Solutions
  • 4.10.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 Device
    • 5.2.1.8 Deployment
    • 5.2.1.9 End User
    • 5.2.1.10 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 Device
    • 5.2.2.8 Deployment
    • 5.2.2.9 End User
    • 5.2.2.10 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 Device
    • 5.2.3.8 Deployment
    • 5.2.3.9 End User
    • 5.2.3.10 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 Device
    • 5.3.1.8 Deployment
    • 5.3.1.9 End User
    • 5.3.1.10 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 Device
    • 5.3.2.8 Deployment
    • 5.3.2.9 End User
    • 5.3.2.10 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 Device
    • 5.3.3.8 Deployment
    • 5.3.3.9 End User
    • 5.3.3.10 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 Device
    • 5.4.1.8 Deployment
    • 5.4.1.9 End User
    • 5.4.1.10 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 Device
    • 5.4.2.8 Deployment
    • 5.4.2.9 End User
    • 5.4.2.10 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 Device
    • 5.4.3.8 Deployment
    • 5.4.3.9 End User
    • 5.4.3.10 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 Device
    • 5.4.4.8 Deployment
    • 5.4.4.9 End User
    • 5.4.4.10 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 Device
    • 5.4.5.8 Deployment
    • 5.4.5.9 End User
    • 5.4.5.10 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 Device
    • 5.4.6.8 Deployment
    • 5.4.6.9 End User
    • 5.4.6.10 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 Device
    • 5.4.7.8 Deployment
    • 5.4.7.9 End User
    • 5.4.7.10 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 Device
    • 5.5.1.8 Deployment
    • 5.5.1.9 End User
    • 5.5.1.10 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 Device
    • 5.5.2.8 Deployment
    • 5.5.2.9 End User
    • 5.5.2.10 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 Device
    • 5.5.3.8 Deployment
    • 5.5.3.9 End User
    • 5.5.3.10 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 Device
    • 5.5.4.8 Deployment
    • 5.5.4.9 End User
    • 5.5.4.10 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 Device
    • 5.5.5.8 Deployment
    • 5.5.5.9 End User
    • 5.5.5.10 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 Device
    • 5.5.6.8 Deployment
    • 5.5.6.9 End User
    • 5.5.6.10 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 Device
    • 5.6.1.8 Deployment
    • 5.6.1.9 End User
    • 5.6.1.10 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 Device
    • 5.6.2.8 Deployment
    • 5.6.2.9 End User
    • 5.6.2.10 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 Device
    • 5.6.3.8 Deployment
    • 5.6.3.9 End User
    • 5.6.3.10 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 Device
    • 5.6.4.8 Deployment
    • 5.6.4.9 End User
    • 5.6.4.10 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 Device
    • 5.6.5.8 Deployment
    • 5.6.5.9 End User
    • 5.6.5.10 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Medtronic
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Philips Healthcare
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Abbott Laboratories
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Roche
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Johnson and Johnson
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 GE Healthcare
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Siemens Healthineers
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Dexcom
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Omron Healthcare
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 ResMed
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Becton Dickinson
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Boston Scientific
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Tandem Diabetes Care
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Insulet Corporation
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Ascensia Diabetes Care
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 iHealth Labs
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 AliveCor
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Withings
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 BioTelemetry
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Welch Allyn
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us